IPO GMP Update: Senores Pharmaceuticals, Ventive Hospitality, Unimech Aerospace, and Carraro India
According to market observers, the Senores Pharmaceuticals IPO's GMP indicates a projected 73% listing gain for successful allottees.
12/29/20241 min read
As the Indian stock market gears up for an exciting week, four major IPOs are set to make their debut on the mainboard. The IPOs include Senores Pharmaceuticals, Ventive Hospitality, Carraro India, and Unimech Aerospace. Following the allotment announcements for these IPOs, market participants are eagerly anticipating their listing dates.
Listing Schedule
Senores Pharmaceuticals IPO, Ventive Hospitality IPO, and Carraro India IPO will be listed on 30 December 2024 (Monday).
Unimech Aerospace IPO is expected to debut a day later, on 31 December 2024 (Tuesday).
IPO GMP Insights
The grey market premium (GMP) for these IPOs is providing key signals ahead of their listing dates, reflecting investor sentiment and potential listing gains. Here's the breakdown:
Senores Pharmaceuticals IPO GMP
Current GMP: ₹283
Expected Listing Price: ₹674 ( ₹391 + ₹283)
Estimated Listing Gain: 72.38%
The strong GMP for Senores Pharmaceuticals suggests substantial investor interest, pointing toward impressive listing gains for allottees.
Ventive Hospitality IPO GMP
Current GMP: ₹82
Expected Listing Price: ₹726 ( ₹643 + ₹83)
Estimated Listing Gain: 13%
The moderate GMP for Ventive Hospitality indicates a stable listing with potential gains for its investors.
Unimech Aerospace IPO GMP
Current GMP: ₹718
Expected Listing Price: ₹1,451 ( ₹785 + ₹718)
Estimated Listing Gain: 91.46%
Unimech Aerospace is leading the pack with the highest GMP, signaling exceptional listing gains and robust market demand.
Carraro India IPO GMP
Current GMP: ₹5
Expected Listing Price: ₹709 (₹704 + ₹5)
Estimated Listing Gain: 0.7%
Carraro India IPO is trading at par in the grey market, suggesting a neutral sentiment with no immediate premium or discount.
Conclusion
The grey market activity ahead of the listing dates highlights the potential of these IPOs, particularly for Senores Pharmaceuticals and Unimech Aerospace, which are expected to deliver exceptional returns. However, investors are advised to exercise caution and consult with certified financial advisors before making investment decisions.
Disclaimer: The information presented is based on market observations and does not constitute financial advice. Always perform your due diligence before investing.